Risk of chronic kidney disease in newly diagnosed systemic lupus erythematosus with preserved renal function: a national study
Clicks: 1
ID: 317589
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #162 of 202 articles by views in Lara D. Veeken
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 202 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Objectives Systemic lupus erythematosus (SLE) is strongly associated with lupus nephritis (LN), a major cause of chronic kidney disease (CKD). However, long-term renal and cardiovascular outcomes in patients with SLE who have preserved kidney function and do not develop LN remain poorly characterized. We sought to investigate the development of CKD among newly diagnosed patients with SLE who had preserved kidney function and no evidence of concomitant LN at baseline, compared with matched control individuals. Methods A national database study of newly diagnosed patients with SLE between 2015 and 2023. Patients with estimated glomerular filtration rate (eGFR) >60 mL/min/1.73 m2 at diagnosis were matched to non-SLE controls by age, sex, and ethnicity. Patients with LN were excluded. The primary outcome was incident CKD, defined as eGFR ≤60 mL/min/1.73 m2 after diagnosis. Secondary outcomes included end-stage kidney disease (ESKD), major adverse cardiovascular events (MACE), and all-cause mortality. Results We identified 1,145 patients with SLE and 91,681 matched controls, with a median follow-up of 5.77 years and similar baseline eGFR (103 vs 104 mL/min/1.73 m2). SLE was associated with a higher risk of CKD (5.2% vs 2.7%; HR 1.96, 95% CI 1.50–2.54), ESKD (HR 3.13, 95% CI 1.38–7.08), MACE (HR 1.63, 95% CI 1.31–2.04), and all-cause mortality (HR 4.52, 95% CI 3.71–5.50). Mean eGFR trajectories were similar between groups. Diabetes (HR 1.51, 95% CI 1.39–1.64) and hypertension (HR 2.72, 95% CI 2.42–3.07) were the strongest risk factors for CKD and ESKD. Conclusion Patients with SLE and preserved kidney function at diagnosis, without LN, are at increased risk of adverse renal outcomes, cardiovascular events, and mortality, highlighting the importance of long-term monitoring and optimization of modifiable CKD risk factors.
| Reference Key |
openalex_W7164916274
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Iftach Sagy, Itamar Ben Shitrit, Mahmoud Abu‐Shakra, Lior Zeller, Amir Bieber, Keren Cohen-Hagai, S Kivity, Oshrat E Tayer-Shifman |
| Journal | Lara D. Veeken |
| Year | 2026 |
| DOI |
10.1093/rheumatology/keag307
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.